Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 2Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Rectal Neoplasms 1Radiation Injuries 1Multiple Myeloma 1Multiple Chronic Conditions 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Hematologic Neoplasms 1Fatigue 1Cognitive Dysfunction 1Carcinoma, Basal Cell 1Breast Neoplasms 1Breast Neoplasm Female 1Brain Neoplasms 1

Interventions

Imatinib Mesylate 17Dasatinib 8nilotinib 7Cytarabine 5Hydroxyurea 4ponatinib 3Peripheral Blood Stem Cell Transplantation 3Interferon-alpha 3bosutinib 2Surveys and Questionnaires 2Stem Cell Transplantation 2Radiotherapy 2Polymerase Chain Reaction 2Pioglitazone 2Idarubicin 2Cytogenetic Analysis 2Busulfan 2Antilymphocyte Serum 2thymoglobulin 1peginterferon alfa-2a 1flumatinib 1fludarabine phosphate 1Tyrosine Kinase Inhibitors 1Therapeutics 1Registries 1Psychiatric Rehabilitation 1Patient Reported Outcome Measures 1PF-114 1Mycophenolic Acid 1Mitoxantrone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Patient Reported Outcome Measures × Clear all
NCT04663100 2023-12-04

Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence

University of Tennessee

Phase NA Unknown
30 enrolled
LymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Multiple Chronic Conditions, Leukemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡